Search Results

NCCN Updates Recommendations for COVID-19 Vaccination With Information on Bivalent Vaccines, Children With Cancer, and Other Developments NCCN has released updated recommendations from the NCCN Advisory Committee on COVID-19 Vaccination and

NCCN Cancer Experts Answer Questions About COVID-19 Vaccines NCCN has published new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers. The new 4-page patient guide is based on the

The COVID-19 shutdown halted elective procedures and limited in-person meetings, causing the Colorectal Cancer Prevention Network (CCPN) screening program to cease for 3 months. During this time, the CCPN focused on developing virtual patient

vaccine dose. Antibody titers were measured using the SARS-CoV-2 IgG II Quant assay. There was no possibility of collecting the samples within a prespecified window due to the strict COVID-19 restrictions which prevented the patients from attending to

Introduction: The use of telemedicine in the oncology (Onc) setting expanded after March 2020 due to the COVID-19 pandemic. Patients and providers report satisfaction with telemedicine within the context of acute pandemic needs (Darcourt et al, JOP

Updated Guidance for COVID-19 Vaccination From NCCN Recommends Fifth mRNA Shot (Second Booster Dose) for Immunocompromised People On April 27th, 2022, NCCN released the latest recommendations from the NCCN Advisory Committee on COVID-19

Protecting People With Cancer From COVID-19: New Recommendations From Cancer Guidelines Organization On January 4, 2022, NCCN published significant updates to the expert consensus recommendations on vaccination and pre-exposure prophylaxis of

Editor's Note: This editorial was written before the emergence of the omicron variant of COVID-19. Welcome to 2022! By the time you read this, you have probably already put away all those holiday decorations, sworn off overeating, and promised

COVID-19 and Decreases in Cancer Screening As a panel of experts at the NCCN 2021 Virtual Annual Conference explained, hospitals in the Northeast, including Dana-Farber Cancer Institute and Yale Smilow Cancer Hospital, experienced a surge in

As oncologists in the era of coronavirus disease 2019 (COVID-19), we are tasked with caring for patients who are at high risk for adverse effects from the novel coronavirus (SARS-CoV-2). 1 Patients with cancer face fear and anxiety related to their